{"id":28372,"date":"2026-05-29T14:07:09","date_gmt":"2026-05-29T21:07:09","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?post_type=faq&#038;p=28372"},"modified":"2026-05-29T14:29:10","modified_gmt":"2026-05-29T21:29:10","slug":"who-qualifies-for-immunotherapy","status":"publish","type":"faq","link":"https:\/\/ameripharmaspecialty.com\/es\/faq\/who-qualifies-for-immunotherapy\/","title":{"rendered":"\u00bfQui\u00e9nes pueden optar a la inmunoterapia?"},"content":{"rendered":"<ul class=\"wp-block-list\">\n<li>No todas las personas con c\u00e1ncer son candidatas a la inmunoterapia. La elegibilidad depende de factores como el tipo de c\u00e1ncer, la etapa de la enfermedad, biomarcadores tumorales espec\u00edficos y el estado de salud general.&nbsp;<\/li>\n\n\n\n<li>La decisi\u00f3n suele tomarse caso por caso por el equipo de oncolog\u00eda del paciente.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Factores que influyen en la elegibilidad para la inmunoterapia<\/h2>\n\n\n\n<p>Un m\u00e9dico normalmente evaluar\u00e1:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tipo y estadio del c\u00e1ncer<\/strong> - alguno <a href=\"https:\/\/www.cancer.org\/cancer\/managing-cancer\/treatment-types\/immunotherapy.html\">inmunoterapias<\/a> Solo est\u00e1n aprobados para enfermedades avanzadas o metast\u00e1sicas.<\/li>\n\n\n\n<li><strong>Pruebas de biomarcadores<\/strong> \u2014 Los laboratorios pueden analizar la expresi\u00f3n de PD-L1, la inestabilidad de microsat\u00e9lites (MSI-H), la deficiencia de reparaci\u00f3n de errores de emparejamiento (dMMR) o la carga mutacional tumoral (TMB) para predecir la respuesta.<\/li>\n\n\n\n<li><strong>Tratamientos previos<\/strong> \u2014 Algunos f\u00e1rmacos de inmunoterapia se aprueban despu\u00e9s de haber probado la quimioterapia; otros se utilizan como tratamiento de primera l\u00ednea.<\/li>\n\n\n\n<li><strong>Estado general de salud y rendimiento<\/strong> \u2014 Los pacientes deben estar lo suficientemente sanos como para tolerar los posibles efectos secundarios relacionados con el sistema inmunitario.<\/li>\n\n\n\n<li><strong>enfermedades autoinmunes<\/strong> \u2014 Las enfermedades autoinmunes preexistentes pueden aumentar el riesgo de efectos secundarios y podr\u00edan afectar la elegibilidad.\n<ul class=\"wp-block-list\"><\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Tratamiento de inmunoterapia contra el c\u00e1ncer aprobado por la FDA<\/h2>\n\n\n\n<p>La FDA ha aprobado <a href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/immunotherapy\">tratamientos de inmunoterapia para el c\u00e1ncer<\/a> como:<\/p>\n\n\n\n<p><\/p>\n\n\n<ul>\n<li><strong>C\u00e1ncer de vejiga, c\u00e1ncer de ri\u00f1\u00f3n, c\u00e1ncer de h\u00edgado<\/strong> \u2014 M\u00faltiples opciones aprobadas por la FDA disponibles<\/li>\n<\/ul>\n\n<ul>\n<li><strong>C\u00e1nceres de cabeza y cuello<\/strong> \u2014 aprobado para enfermedad recurrente o metast\u00e1sica<\/li>\n<\/ul>\n\n<ul>\n<li><strong>Ciertos tipos de c\u00e1ncer de sangre<\/strong> (Linfoma de Hodgkin, linfoma no Hodgkin, leucemia) \u2014 La terapia con c\u00e9lulas CAR-T y los inhibidores de puntos de control pueden ser \u00fatiles.<\/li>\n<\/ul>\n\n\n<p><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>C\u00e1ncer colorrectal con biomarcadores espec\u00edficos<\/strong> (Estado MSI-H o dMMR)<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Algunos tumores s\u00f3lidos<\/strong> con alta carga mutacional tumoral (TMB-H), independientemente del tipo de c\u00e1ncer.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p>Aqu\u00ed encontrar\u00e1 m\u00e1s informaci\u00f3n sobre el c\u00e1ncer y los medicamentos de inmunoterapia contra el c\u00e1ncer:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/es\/conditions-treatments\/cancer\/\">https:\/\/ameripharmaspecialty.com\/conditions-treatments\/cancer\/<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/understanding-gazyva-an-immunotherapy-cancer-medication\/\">https:\/\/ameripharmaspecialty.com\/cancer\/understanding-gazyva-an-immunotherapy-cancer-medication\/<\/a><\/li>\n<\/ul>","protected":false},"author":30,"featured_media":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-28372","faq","type-faq","status-publish","format-standard","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Who Qualifies for Immunotherapy? | AmeriPharma Specialty Care<\/title>\n<meta name=\"description\" content=\"Not every patient qualifies for immunotherapy. Learn which cancer types and biomarkers may make you eligible, and how AmeriPharma Specialty Care supports patients through treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Who Qualifies for Immunotherapy? | AmeriPharma Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Not every patient qualifies for immunotherapy. Learn which cancer types and biomarkers may make you eligible, and how AmeriPharma Specialty Care supports patients through treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-29T21:29:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpengine.com\\\/faq\\\/who-qualifies-for-immunotherapy\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspe.wpengine.com\\\/faq\\\/who-qualifies-for-immunotherapy\\\/\",\"name\":\"Who Qualifies for Immunotherapy? | AmeriPharma Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"datePublished\":\"2026-05-29T21:07:09+00:00\",\"dateModified\":\"2026-05-29T21:29:10+00:00\",\"description\":\"Not every patient qualifies for immunotherapy. Learn which cancer types and biomarkers may make you eligible, and how AmeriPharma Specialty Care supports patients through treatment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpengine.com\\\/faq\\\/who-qualifies-for-immunotherapy\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspe.wpengine.com\\\/faq\\\/who-qualifies-for-immunotherapy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpengine.com\\\/faq\\\/who-qualifies-for-immunotherapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspe.wpengine.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FAQ\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/immunotherapy-faqs\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Who Qualifies for Immunotherapy?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Who Qualifies for Immunotherapy? | AmeriPharma Specialty Care","description":"Not every patient qualifies for immunotherapy. Learn which cancer types and biomarkers may make you eligible, and how AmeriPharma Specialty Care supports patients through treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/","og_locale":"es_MX","og_type":"article","og_title":"Who Qualifies for Immunotherapy? | AmeriPharma Specialty Care","og_description":"Not every patient qualifies for immunotherapy. Learn which cancer types and biomarkers may make you eligible, and how AmeriPharma Specialty Care supports patients through treatment.","og_url":"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_modified_time":"2026-05-29T21:29:10+00:00","og_image":[{"width":400,"height":400,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/","url":"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/","name":"Who Qualifies for Immunotherapy? | AmeriPharma Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"datePublished":"2026-05-29T21:07:09+00:00","dateModified":"2026-05-29T21:29:10+00:00","description":"Not every patient qualifies for immunotherapy. Learn which cancer types and biomarkers may make you eligible, and how AmeriPharma Specialty Care supports patients through treatment.","breadcrumb":{"@id":"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspe.wpengine.com\/faq\/who-qualifies-for-immunotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspe.wpengine.com\/"},{"@type":"ListItem","position":2,"name":"FAQ","item":"https:\/\/ameripharmaspecialty.com\/vi\/immunotherapy-faqs\/"},{"@type":"ListItem","position":3,"name":"Who Qualifies for Immunotherapy?"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false,"block-image-html-large":false,"ct-gallery":false,"ct-section-header":false,"ct-thumb":false,"ct-thumb-large":false,"ct-small":false,"ct-medium":false,"ct-xmedium":false,"ct-large":false},"uagb_author_info":{"display_name":"TJ","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/tj\/"},"uagb_comment_info":0,"uagb_excerpt":"Factors that Affect Immunotherapy Eligibility A physician will typically evaluate: FDA-Approved Immunotherapy Cancer Treatment The FDA has approved immunotherapy treatments for cancers such as: Bladder cancer, kidney cancer, liver cancer \u2014 multiple FDA-approved options available Head and neck cancers \u2014 approved for recurrent or metastatic disease Certain blood cancers (Hodgkin lymphoma, non-Hodgkin lymphoma, leukemia) \u2014","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/faq\/28372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/faq"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/faq"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/30"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/faq\/28372\/revisions"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=28372"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}